Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CG Oncology, Inc. - Common stock (NQ: CGON ) 34.22 -0.18 (-0.52%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 468,517 Open 34.43 Bid (Size) 32.00 (2) Ask (Size) 36.00 (1) Prev. Close 34.40 Today's Range 33.77 - 35.24 52wk Range 25.77 - 50.23 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CGON Stock Earnings: CG Oncology Beats EPS for Q2 2024 August 08, 2024 CGON stock results show that CG Oncology beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates August 08, 2024 From CG Oncology Inc. Via GlobeNewswire Performance YTD -13.69% -13.69% 1 Month -10.42% -10.42% 3 Month +14.14% +14.14% 6 Month -28.60% -28.60% 1 Year -13.69% -13.69% More News Read More A Closer Look at 9 Analyst Recommendations For CG Oncology June 28, 2024 Via Benzinga CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec June 18, 2024 From CG Oncology Inc. Via GlobeNewswire Decoding 10 Analyst Evaluations For CG Oncology May 14, 2024 Via Benzinga CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC June 06, 2024 From CG Oncology Inc. Via GlobeNewswire Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 03, 2024 Via Benzinga Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday June 03, 2024 Via Benzinga CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting May 24, 2024 From CG Oncology Inc. Via GlobeNewswire CGON Stock Earnings: CG Oncology Misses EPS for Q1 2024 May 09, 2024 Via InvestorPlace CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates May 09, 2024 From CG Oncology Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session May 03, 2024 Via Benzinga Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer May 03, 2024 From CG Oncology Inc. Via GlobeNewswire Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday May 03, 2024 Via Benzinga CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024 April 26, 2024 From CG Oncology Inc. Via GlobeNewswire CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024 April 24, 2024 From CG Oncology Inc. Via GlobeNewswire IPO Stocks: Will Reddit Unplug The Bulging U.S. IPO Pipeline? March 28, 2024 Via Investor's Business Daily Topics Initial Public Offering Exposures Securities Market CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting March 28, 2024 From CG Oncology Inc. Via GlobeNewswire CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer February 27, 2024 From CG Oncology Inc. Via GlobeNewswire Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys? February 25, 2024 Via The Motley Fool Topics Initial Public Offering Exposures Securities Market 3 attractive stocks that insiders are buying February 12, 2024 Via MarketBeat CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday February 12, 2024 Via Benzinga Topics Stocks Exposures US Equities CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares January 30, 2024 From CG Oncology, Inc. Via Business Wire KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower January 28, 2024 Via Talk Markets Topics Initial Public Offering Exposures Securities Market KLA Reports Q2 Results, Joins Visa, Western Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session January 26, 2024 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
